Revero operates a subscription-based virtual-care platform that combines precision nutrition, machine learning and continuous personalized care delivered by clinicians. The company targets partnerships with self-insured employers and health plans to scale access. It plans to expand the platform to provide full-scope medical treatment across all 50 US states and to extend services to additional metabolic conditions such as type-2 diabetes, heart disease, and mental health issues including anxiety and depression. Founded in 2019 and led by CEO Mahsa Rostami, Revero is based in San Francisco. The company grew to nearly 3,000 paying subscribers, achieved a 56% compound growth rate, and reported annual revenue of more than $500K.

Total raised

$5M

Funding rounds

1

Latest round

Seed

Latest activity

Nov 2022